Prospective Evaluation of Germline Alterations in Patients With Exocrine Pancreatic Neoplasms.

doi:10.1093/jnci/djy024

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Prospective Evaluation of Germline Alterations in Patients With Exocrine Pancreatic Neoplasms.

Journal of the National Cancer Institute - 1 Oct 2018

Lowery Maeve A, Wong Winston, Jordan Emmet J, Lee Jonathan W, Kemel Yelena, Vijai Joseph, Mandelker Diana, Zehir Ahmet, Capanu Marinela, Salo-Mullen Erin, Arnold Angela G, Yu Kenneth H, Varghese Anna M, Kelsen David P, Brenner Robin, Kaufmann Erica, Ravichandran Vignesh, Mukherjee Semanti, Berger Michael F, Hyman David M, Klimstra David S, Abou-Alfa Ghassan K, Tjan Catherine, Covington Christina, Maynard Hannah, Allen Peter J, Askan Gokce, Leach Steven D, Iacobuzio-Donahue Christine A, Robson Mark E, Offit Kenneth, Stadler Zsofia K, O'Reilly Eileen M

Abstract excerpt

Background: Identification of pathogenic germline alterations (PGAs) has important clinical and therapeutic implications in pancreas cancer. We performed comprehensive germline testing (GT) in an unselected prospective cohort of patients with exocrine pancreatic neoplasms with genotype and phenotype association to facilitate identification of prognostic and/or predictive biomarkers and examine potential...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Antineoplastic Combined Chemotherapy Protocols

Share to Biomarkers, Tumor

Share to Germ-Line Mutation

Share to Heterozygote

Share to Kaplan-Meier Estimate

Share to Loss of Heterozygosity

Share to Pancreatic Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 29506128
DOI: 10.1093/jnci/djy024
PMCID: PMC6186514

Genes

BRCA1
ATM
PALB2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prospective Evaluation of Germline Alterations in Patients With Exocrine Pancreatic Neoplasms.PMID 29506128Read ↗

An Emerging Paradigm for Germline Testing in Pancreatic Ductal Adenocarcinoma and Immediate Implications for Clinical Practice: A Review.Semantic proximity Read ↗

Hereditary Pancreatic Cancer: Genetic Risk, Surveillance Strategies, and Therapeutic Implications.Semantic proximity Read ↗

Detection of germline variants using expanded multigene panels in patients with localized pancreatic cancer.Semantic proximity Read ↗

Germline Aberrations in Pancreatic Cancer: Implications for Clinical CareSemantic proximity Read ↗

Uncovering Pathogenic Variants in Cancer Susceptibility Genes through Genetic Testing for Pancreatic Cancer PatientsSemantic proximity Read ↗

Germline Pathogenic Variants in Patients with Pancreatic Ductal Adenocarcinoma and Extra-Pancreatic Malignancies: A Nationwide Database AnalysisSemantic proximity Read ↗

Germline DNA Sequencing Reveals Novel Mutations Predictive of Overall Survival in a Cohort of Patients with Pancreatic Cancer.Semantic proximity Read ↗

Multigene Hereditary Cancer Panels Reveal High-Risk Pancreatic Cancer Susceptibility GenesSemantic proximity Read ↗

Prevalence and spectrum of germline pathogenic variants in cancer susceptibility genes among mexican patients with exocrine pancreatic cancer.Semantic proximity Read ↗

Association Between Inherited Germline Mutations in Cancer Predisposition Genes and Risk of Pancreatic Cancer.Semantic proximity Read ↗

Beyond BRCA: The Emerging Significance of DNA Damage Response and Personalized Treatment in Pancreatic and Prostate Cancer PatientsSemantic proximity Read ↗

Early-Onset Pancreas Cancer: Clinical Descriptors, Genomics, and OutcomesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.